mitomycin has been researched along with Esophageal Stricture in 42 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitomycin C application significantly reduced the number of dilatation sessions needed to alleviate dysphagia in patients with caustic esophageal strictures." | 9.17 | Topical mitomycin C application is effective in management of localized caustic esophageal stricture: a double-blinded, randomized, placebo-controlled trial. ( Abdelkader, HM; El-Asmar, KM; Hamza, AF; Hassan, MA, 2013) |
| "This prospective study aimed to evaluate the feasibility and safety of locoregional mitomycin C (MMC) injection to treat refractory esophageal strictures after endoscopic submucosal dissection (ESD) for superficial esophageal carcinoma." | 9.16 | Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. ( Arakawa, T; Fujiwara, Y; Machida, H; Minamino, H; Okazaki, H; Sugimori, S; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H, 2012) |
| " The question addressed was 'Can mitomycin facilitate endoscopic dilatation treatment of benign esophageal stricture (mainly including caustic and anastomotic esophageal stricture)?' Altogether, 115 papers were found using the reported search, of which 6 represented the best evidence to answer the clinical question, which included 1 randomized controlled trial, 1 systematic review and 4 cohort studies." | 8.95 | Can mitomycin facilitate endoscopic dilatation treatment of benign oesophageal stricture? ( Chen, LQ; Deng, HY; Lin, YD; Wang, WP, 2017) |
| "To determine the efficacy of topical Mitomycin C application for recurrent benign esophageal strictures." | 8.93 | Topical Mitomycin C application in the treatment of refractory benign esophageal strictures in adults and comprehensive literature review. ( Bartel, MJ; Clayton, D; Jeffers, K; Raimondo, M; Seeger, K; Wallace, MB; Woodward, TA, 2016) |
| "The short-term results of topical Mitomycin C application for refractory esophageal stricture reported in the literature are very encouraging." | 8.88 | Mitomycin C in the therapy of recurrent esophageal strictures: hype or hope? ( Berger, M; Lacher, M; Ure, B, 2012) |
| "The aim of this study was to investigate the efficacy and safety of endoscopic local infiltration of mitomycin C (MMC) after oesophageal dilation for children suffering from refractory postcorrosive oesophageal stricture (OS)." | 7.91 | Short-term Effects of Mitomycin C Infiltration for Caustic Oesophageal Strictures in Children. ( Abdullateef, KS; Arafa, A; Elkadi, R; Mansour, O; Mohamed, W; Qinawy, M; Raslan, H; Seleim, H; Wishahy, AMK; Yassin, T, 2019) |
| "There was a highly significant difference in the improvement of dysphagia grade at the end of follow up in the mitomycin C group (p=0." | 7.81 | A prospective controlled study to assess the use of mitomycin C in improving the results of esophageal dilatation in post corrosive esophageal stricture in children. ( Ezzat, WF; Fawaz, SA; Sabri, SM; Sweed, AS, 2015) |
| "Intramuscular injection of mitomycin C or dexamethasone may prolong the dysphagia-free period and decrease the frequency of repeat dilations compared with conventional endoscopic dilations in patients with benign esophageal strictures." | 7.81 | Intramuscular injection of mitomycin C combined with endoscopic dilation for benign esophageal strictures. ( Chen, JP; Fan, ZN; Liu, L; Wang, X; Zhang, Y, 2015) |
| " In 12 patients of caustic induced esophageal stricture, who failed to respond despite rigorous dilatation regimen for more than one year, a trial of topical mitomycin-C application to improve dilatation results was undertaken, considering the recently reported efficacy and safety of this agent." | 7.80 | Mitomycin-C: 'a ray of hope' in refractory corrosive esophageal strictures. ( Katiyar, P; Nagaich, N; Nijhawan, S; Rathore, M; Sharma, R, 2014) |
| "The aim of the present study was to evaluate the efficacy and short-term safety of topical mitomycin-C, an antifibrotic agent, in preventing the recurrence of anastomotic strictures after surgical repair of esophageal atresia (EA)." | 7.80 | Topical mitomycin-C application in recurrent esophageal strictures after surgical repair of esophageal atresia. ( Chapuy, L; Faure, C; Pomerleau, M, 2014) |
| " We report the successful use of mitomycin C in a young boy in whom we could achieve ongoing relief of dysphagia after the unsuccessful long-term use of frequent endoscopic dilatations." | 7.74 | [Topical mitomycin C treatment of a benign oesophageal stricture following caustic ingestion in a four-year-old boy]. ( Fröhlich, T; Greess, H; Köhler, H, 2007) |
| "We describe a novel technique of endoluminal delivery and focused application of mitomycin-C to an esophageal stricture that avoids inadvertent topical application to adjacent mucosa." | 7.74 | Topical mitomycin-C for recalcitrant esophageal strictures: a novel endoscopic/fluoroscopic technique for safe endoluminal delivery. ( Baird, R; Blair, GK; Heran, MK; Skarsgard, ED, 2008) |
| "Mitomycin C is an antiproliferative agent that has been used successfully as an adjunct treatment in ophthalmological procedures, in the management of laryngeal and tracheal stenosis, and more recently to prevent the recurrence of caustic esophageal strictures in children." | 7.73 | Mitomycin C: an alternative conservative treatment for refractory esophageal stricture in children? ( Fayoux, P; Gottrand, F; Guimber, D; Michaud, L; Turck, D; Uhlen, S; Vachin, F, 2006) |
| "To assess the role of mitomycin C (MMC) in the management of pharyngoesophageal stricture after total laryngopharyngectomy and free flap reconstruction." | 7.72 | Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction. ( Annino, DJ; Goguen, LA, 2003) |
| "Research on long-term use of mitomycin C (MC) for recurrent esophageal stenoses is limited." | 5.51 | Efficacy and Safety of the Local Application of Mitomycin C to Recurrent Esophageal Strictures in Children. ( Bridenne, M; Fayoux, P; Gottrand, F; Hauser, B; Lachaux, A; Lemale, J; Ley, D; Michaud, L; Rebouissoux, L; Viala, J, 2019) |
| "The median dysphagia score decreased from 2 (1 to 3) to 0 (0 to 2) after application (P<0." | 5.46 | Topical Mitomycin C Application Is Effective Even in Esophageal Strictures Resistant to Dilatation Therapy in Children. ( Divarci, E; Dokumcu, Z; Erdener, A; Kilic, O; Ozcan, C, 2017) |
| "Mitomycin-C 0." | 5.34 | Topical application of mitomycin-C in oesophageal strictures. ( Afzal, N; Cameron, D; Ibarguen-Secchia, E; Köhler, H; Lewindon, P; Lindley, KJ; Mahler, T; Rosseneu, S; Schwagten, K; Thomson, M; Yerushalmi, B, 2007) |
| "Mitomycin C application significantly reduced the number of dilatation sessions needed to alleviate dysphagia in patients with caustic esophageal strictures." | 5.17 | Topical mitomycin C application is effective in management of localized caustic esophageal stricture: a double-blinded, randomized, placebo-controlled trial. ( Abdelkader, HM; El-Asmar, KM; Hamza, AF; Hassan, MA, 2013) |
| "This prospective study aimed to evaluate the feasibility and safety of locoregional mitomycin C (MMC) injection to treat refractory esophageal strictures after endoscopic submucosal dissection (ESD) for superficial esophageal carcinoma." | 5.16 | Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. ( Arakawa, T; Fujiwara, Y; Machida, H; Minamino, H; Okazaki, H; Sugimori, S; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H, 2012) |
| " The question addressed was 'Can mitomycin facilitate endoscopic dilatation treatment of benign esophageal stricture (mainly including caustic and anastomotic esophageal stricture)?' Altogether, 115 papers were found using the reported search, of which 6 represented the best evidence to answer the clinical question, which included 1 randomized controlled trial, 1 systematic review and 4 cohort studies." | 4.95 | Can mitomycin facilitate endoscopic dilatation treatment of benign oesophageal stricture? ( Chen, LQ; Deng, HY; Lin, YD; Wang, WP, 2017) |
| "To determine the efficacy of topical Mitomycin C application for recurrent benign esophageal strictures." | 4.93 | Topical Mitomycin C application in the treatment of refractory benign esophageal strictures in adults and comprehensive literature review. ( Bartel, MJ; Clayton, D; Jeffers, K; Raimondo, M; Seeger, K; Wallace, MB; Woodward, TA, 2016) |
| "The short-term results of topical Mitomycin C application for refractory esophageal stricture reported in the literature are very encouraging." | 4.88 | Mitomycin C in the therapy of recurrent esophageal strictures: hype or hope? ( Berger, M; Lacher, M; Ure, B, 2012) |
| "The aim of this study was to investigate the efficacy and safety of endoscopic local infiltration of mitomycin C (MMC) after oesophageal dilation for children suffering from refractory postcorrosive oesophageal stricture (OS)." | 3.91 | Short-term Effects of Mitomycin C Infiltration for Caustic Oesophageal Strictures in Children. ( Abdullateef, KS; Arafa, A; Elkadi, R; Mansour, O; Mohamed, W; Qinawy, M; Raslan, H; Seleim, H; Wishahy, AMK; Yassin, T, 2019) |
| "There was a highly significant difference in the improvement of dysphagia grade at the end of follow up in the mitomycin C group (p=0." | 3.81 | A prospective controlled study to assess the use of mitomycin C in improving the results of esophageal dilatation in post corrosive esophageal stricture in children. ( Ezzat, WF; Fawaz, SA; Sabri, SM; Sweed, AS, 2015) |
| "Intramuscular injection of mitomycin C or dexamethasone may prolong the dysphagia-free period and decrease the frequency of repeat dilations compared with conventional endoscopic dilations in patients with benign esophageal strictures." | 3.81 | Intramuscular injection of mitomycin C combined with endoscopic dilation for benign esophageal strictures. ( Chen, JP; Fan, ZN; Liu, L; Wang, X; Zhang, Y, 2015) |
| "The aim of the present study was to evaluate the efficacy and short-term safety of topical mitomycin-C, an antifibrotic agent, in preventing the recurrence of anastomotic strictures after surgical repair of esophageal atresia (EA)." | 3.80 | Topical mitomycin-C application in recurrent esophageal strictures after surgical repair of esophageal atresia. ( Chapuy, L; Faure, C; Pomerleau, M, 2014) |
| " In 12 patients of caustic induced esophageal stricture, who failed to respond despite rigorous dilatation regimen for more than one year, a trial of topical mitomycin-C application to improve dilatation results was undertaken, considering the recently reported efficacy and safety of this agent." | 3.80 | Mitomycin-C: 'a ray of hope' in refractory corrosive esophageal strictures. ( Katiyar, P; Nagaich, N; Nijhawan, S; Rathore, M; Sharma, R, 2014) |
| "Twelve patients with progressive dysphagia and video-fluoroscopic evidence of upper digestive tract stricture after head and neck cancer treatment were dilated by Maloney or Savory dilators followed by the application of mitomycin C (0." | 3.74 | Role of mitomycin in upper digestive tract stricture. ( Brodsky, MB; Day, TA; Gillespie, MB; Martin-Harris, B; Sharma, AK, 2007) |
| " We report the successful use of mitomycin C in a young boy in whom we could achieve ongoing relief of dysphagia after the unsuccessful long-term use of frequent endoscopic dilatations." | 3.74 | [Topical mitomycin C treatment of a benign oesophageal stricture following caustic ingestion in a four-year-old boy]. ( Fröhlich, T; Greess, H; Köhler, H, 2007) |
| "We describe a novel technique of endoluminal delivery and focused application of mitomycin-C to an esophageal stricture that avoids inadvertent topical application to adjacent mucosa." | 3.74 | Topical mitomycin-C for recalcitrant esophageal strictures: a novel endoscopic/fluoroscopic technique for safe endoluminal delivery. ( Baird, R; Blair, GK; Heran, MK; Skarsgard, ED, 2008) |
| " The purpose of this study was to investigate the effectiveness of Mitomycin C (MMC), which inhibits fibroblastic proliferation in preventing caustic esophageal strictures." | 3.73 | Mitomycin C prevents strictures in caustic esophageal burns in rats. ( Başaklar, AC; Demirtola, A; Dinçer, S; Gülen, S; Kale, N; Karabulut, R; Poyraz, A; Sönmez, K; Türkyilmaz, Z, 2005) |
| "Mitomycin C is an antiproliferative agent that has been used successfully as an adjunct treatment in ophthalmological procedures, in the management of laryngeal and tracheal stenosis, and more recently to prevent the recurrence of caustic esophageal strictures in children." | 3.73 | Mitomycin C: an alternative conservative treatment for refractory esophageal stricture in children? ( Fayoux, P; Gottrand, F; Guimber, D; Michaud, L; Turck, D; Uhlen, S; Vachin, F, 2006) |
| "To assess the role of mitomycin C (MMC) in the management of pharyngoesophageal stricture after total laryngopharyngectomy and free flap reconstruction." | 3.72 | Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction. ( Annino, DJ; Goguen, LA, 2003) |
| "Fifteen patients; choanal atresia in 5 patients, airway stenosis in 8 patients, hypopharyngeal stenosis in 1 patient, and esophageal stenosis in 1 patient." | 2.70 | The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: friend or foe? ( Healy, GB; Jones, DT; Kenna, MA; McGill, TJ; Nuss, RC; Rahbar, R; Roberson, DW, 2002) |
| "Research on long-term use of mitomycin C (MC) for recurrent esophageal stenoses is limited." | 1.51 | Efficacy and Safety of the Local Application of Mitomycin C to Recurrent Esophageal Strictures in Children. ( Bridenne, M; Fayoux, P; Gottrand, F; Hauser, B; Lachaux, A; Lemale, J; Ley, D; Michaud, L; Rebouissoux, L; Viala, J, 2019) |
| "The median dysphagia score decreased from 2 (1 to 3) to 0 (0 to 2) after application (P<0." | 1.46 | Topical Mitomycin C Application Is Effective Even in Esophageal Strictures Resistant to Dilatation Therapy in Children. ( Divarci, E; Dokumcu, Z; Erdener, A; Kilic, O; Ozcan, C, 2017) |
| "Refractory esophageal stenosis (RES) is a major health problem in the pediatric population." | 1.43 | Management of refractory esophageal stenosis in the pediatric age. ( Alberca de Las Parras, F; Egea Valenzuela, J; Navalón Rubio, M, 2016) |
| "7 % high dose), while both TGF-β3 dosage groups showed no significant change (65." | 1.40 | Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures. ( Chak, A; Cipriano, C; Lash, RH; Marks, JM; Ponsky, JL; Schomisch, SJ; Wu, Y, 2014) |
| "Mitomycin-C 0." | 1.34 | Topical application of mitomycin-C in oesophageal strictures. ( Afzal, N; Cameron, D; Ibarguen-Secchia, E; Köhler, H; Lewindon, P; Lindley, KJ; Mahler, T; Rosseneu, S; Schwagten, K; Thomson, M; Yerushalmi, B, 2007) |
| "He consequently presented severe stenosis at the origin of the cervical esophagus that needed repeated balloon dilatations." | 1.34 | Topical application of mitomycin C in the treatment of esophageal and tracheobronchial stricture: a report of 2 cases. ( Adib, M; Daher, P; Georges, B; Georges, D; Riachy, E, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (35.71) | 29.6817 |
| 2010's | 26 (61.90) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Wishahy, AMK | 1 |
| Seleim, H | 1 |
| Qinawy, M | 1 |
| Mohamed, W | 1 |
| Mansour, O | 1 |
| Abdullateef, KS | 1 |
| Elkadi, R | 1 |
| Raslan, H | 1 |
| Arafa, A | 1 |
| Yassin, T | 1 |
| Ley, D | 1 |
| Bridenne, M | 1 |
| Gottrand, F | 2 |
| Lemale, J | 1 |
| Hauser, B | 1 |
| Lachaux, A | 1 |
| Rebouissoux, L | 1 |
| Viala, J | 1 |
| Fayoux, P | 3 |
| Michaud, L | 3 |
| Hoffman, RS | 1 |
| Burns, MM | 1 |
| Gosselin, S | 1 |
| Divarci, E | 1 |
| Kilic, O | 1 |
| Dokumcu, Z | 1 |
| Ozcan, C | 1 |
| Erdener, A | 1 |
| Madadi-Sanjani, O | 1 |
| Zimmer, J | 1 |
| Gosemann, JH | 1 |
| Ure, BM | 1 |
| Lacher, M | 2 |
| Boehm, R | 1 |
| Ghobrial, CM | 1 |
| Eskander, AE | 1 |
| Siersema, PD | 1 |
| Nagaich, N | 1 |
| Nijhawan, S | 1 |
| Katiyar, P | 1 |
| Sharma, R | 1 |
| Rathore, M | 1 |
| El-Asmar, KM | 3 |
| Hassan, MA | 2 |
| Abdelkader, HM | 2 |
| Hamza, AF | 2 |
| Wu, Y | 1 |
| Schomisch, SJ | 1 |
| Cipriano, C | 1 |
| Chak, A | 1 |
| Lash, RH | 1 |
| Ponsky, JL | 1 |
| Marks, JM | 1 |
| Chapuy, L | 1 |
| Pomerleau, M | 1 |
| Faure, C | 1 |
| Sweed, AS | 1 |
| Fawaz, SA | 1 |
| Ezzat, WF | 1 |
| Sabri, SM | 1 |
| Zhang, Y | 1 |
| Wang, X | 1 |
| Liu, L | 1 |
| Chen, JP | 1 |
| Fan, ZN | 1 |
| Shub, MD | 1 |
| Manfredi, MA | 1 |
| Bartel, MJ | 1 |
| Seeger, K | 1 |
| Jeffers, K | 1 |
| Clayton, D | 1 |
| Wallace, MB | 1 |
| Raimondo, M | 1 |
| Woodward, TA | 1 |
| Alberca de Las Parras, F | 1 |
| Navalón Rubio, M | 1 |
| Egea Valenzuela, J | 1 |
| Deng, HY | 1 |
| Wang, WP | 1 |
| Lin, YD | 1 |
| Chen, LQ | 1 |
| Poincloux, L | 1 |
| Rouquette, O | 1 |
| Abergel, A | 1 |
| Chiang, AL | 1 |
| Abidi, WM | 1 |
| Thompson, CC | 1 |
| Spier, BJ | 1 |
| Sawma, VA | 1 |
| Gopal, DV | 1 |
| Reichelderfer, M | 1 |
| Türkyilmaz, Z | 2 |
| Sönmez, K | 2 |
| Karabulut, R | 2 |
| Gülbahar, O | 1 |
| Poyraz, A | 2 |
| Sancak, B | 1 |
| Başaklar, AC | 2 |
| Chung, J | 1 |
| Connolly, B | 1 |
| Langer, J | 1 |
| Marcon, M | 1 |
| Temple, M | 1 |
| Amaral, JG | 1 |
| Heran, MKS | 1 |
| Pham, TH | 1 |
| Butterworth, S | 1 |
| Robinson, A | 1 |
| Berger, M | 1 |
| Ure, B | 1 |
| Machida, H | 1 |
| Tominaga, K | 1 |
| Minamino, H | 1 |
| Sugimori, S | 1 |
| Okazaki, H | 1 |
| Yamagami, H | 1 |
| Tanigawa, T | 1 |
| Watanabe, K | 1 |
| Watanabe, T | 1 |
| Fujiwara, Y | 1 |
| Arakawa, T | 1 |
| Bustamante, TF | 1 |
| Lourenção, PL | 1 |
| Higa, KL | 1 |
| Silva, AP | 1 |
| Ortolan, EV | 1 |
| Annino, DJ | 1 |
| Goguen, LA | 1 |
| Demirtola, A | 1 |
| Gülen, S | 1 |
| Dinçer, S | 1 |
| Kale, N | 1 |
| Uhlen, S | 2 |
| Vachin, F | 1 |
| Guimber, D | 1 |
| Turck, D | 1 |
| Olutoye, OO | 1 |
| Shulman, RJ | 1 |
| Cotton, RT | 1 |
| Gillespie, MB | 1 |
| Day, TA | 1 |
| Sharma, AK | 1 |
| Brodsky, MB | 1 |
| Martin-Harris, B | 1 |
| Rosseneu, S | 1 |
| Afzal, N | 1 |
| Yerushalmi, B | 1 |
| Ibarguen-Secchia, E | 1 |
| Lewindon, P | 1 |
| Cameron, D | 1 |
| Mahler, T | 1 |
| Schwagten, K | 1 |
| Köhler, H | 2 |
| Lindley, KJ | 1 |
| Thomson, M | 2 |
| Fröhlich, T | 1 |
| Greess, H | 1 |
| Broto, J | 1 |
| Gil-Vernet, JM | 1 |
| Royo, G | 1 |
| Cabañas, MJ | 1 |
| Daher, P | 1 |
| Riachy, E | 1 |
| Georges, B | 1 |
| Georges, D | 1 |
| Adib, M | 1 |
| Heran, MK | 1 |
| Baird, R | 1 |
| Blair, GK | 1 |
| Skarsgard, ED | 1 |
| Rahbar, R | 1 |
| Jones, DT | 1 |
| Nuss, RC | 1 |
| Roberson, DW | 1 |
| Kenna, MA | 1 |
| McGill, TJ | 1 |
| Healy, GB | 1 |
| Afzal, NA | 1 |
| Albert, D | 1 |
| Thomas, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children[NCT04524897] | Phase 4 | 20 participants (Anticipated) | Interventional | 2020-12-01 | Not yet recruiting | ||
| Effectiveness Evaluation of Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Early Esophageal Cancer Invading More Than 2/3 Esophageal Perimeter[NCT03165344] | 66 participants (Actual) | Interventional | 2017-02-10 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for mitomycin and Esophageal Stricture
| Article | Year |
|---|---|
Ingestion of Caustic Substances.
Topics: Acids; Adult; Alkalies; Burns, Chemical; Caustics; Child; Endoscopy, Digestive System; Esophageal Pe | 2020 |
Therapy of caustic ingestion: new treatment considerations.
Topics: Accidents; Alkylating Agents; Burns, Chemical; Caustics; Child; Child, Preschool; Dilatation; Esopha | 2015 |
Endoscopic Management of Anastomotic Esophageal Strictures Secondary to Esophageal Atresia.
Topics: Alkylating Agents; Deglutition Disorders; Dilatation; Esophageal Atresia; Esophageal Stenosis; Esoph | 2016 |
Topical Mitomycin C application in the treatment of refractory benign esophageal strictures in adults and comprehensive literature review.
Topics: Aged; Alkylating Agents; Anastomosis, Surgical; Balloon Occlusion; Caustics; Constriction, Pathologi | 2016 |
Can mitomycin facilitate endoscopic dilatation treatment of benign oesophageal stricture?
Topics: Antibiotics, Antineoplastic; Dilatation; Esophageal Stenosis; Esophagoscopy; Humans; Mitomycin | 2017 |
Endoscopic treatment of benign esophageal strictures: a literature review.
Topics: Absorbable Implants; Dilatation; Esophageal Stenosis; Esophagoscopy; Humans; Injections, Intralesion | 2017 |
Mitomycin C in the therapy of recurrent esophageal strictures: hype or hope?
Topics: Administration, Topical; Child; Child, Preschool; Drug-Eluting Stents; Endoscopy; Esophageal Stenosi | 2012 |
5 trials available for mitomycin and Esophageal Stricture
| Article | Year |
|---|---|
Topical Mitomycin C application for esophageal stricture: safe, precise, and novel endoscopic technique.
Topics: Administration, Topical; Alkylating Agents; Burns, Chemical; Catheters; Child; Combined Modality The | 2013 |
Topical mitomycin C application is effective in management of localized caustic esophageal stricture: a double-blinded, randomized, placebo-controlled trial.
Topics: Administration, Topical; Burns, Chemical; Caustics; Child, Preschool; Double-Blind Method; Esophagea | 2013 |
Topical mitomycin C can effectively alleviate dysphagia in children with long-segment caustic esophageal strictures.
Topics: Administration, Topical; Alkylating Agents; Burns, Chemical; Caustics; Child, Preschool; Deglutition | 2015 |
Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection.
Topics: Aged; Carcinoma; Catheterization; Deglutition Disorders; Dissection; Esophageal Neoplasms; Esophagea | 2012 |
The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: friend or foe?
Topics: Administration, Topical; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Choanal At | 2002 |
30 other studies available for mitomycin and Esophageal Stricture
| Article | Year |
|---|---|
Short-term Effects of Mitomycin C Infiltration for Caustic Oesophageal Strictures in Children.
Topics: Burns, Chemical; Child; Dilatation; Esophageal Stenosis; Esophagoscopy; Female; Humans; Male; Mitomy | 2019 |
Efficacy and Safety of the Local Application of Mitomycin C to Recurrent Esophageal Strictures in Children.
Topics: Administration, Mucosal; Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Esophagea | 2019 |
Topical Mitomycin C Application Is Effective Even in Esophageal Strictures Resistant to Dilatation Therapy in Children.
Topics: Administration, Topical; Adolescent; Alkylating Agents; Chemotherapy, Adjuvant; Child; Child, Presch | 2017 |
Topical Mitomycin C Application in Pediatric Patients with Recurrent Esophageal Strictures-Report on Unfavorable Results.
Topics: Administration, Topical; Adolescent; Alkylating Agents; Child; Child, Preschool; Combined Modality T | 2018 |
Prospective study of the effect of topical application of Mitomycin C in refractory pediatric caustic esophageal strictures.
Topics: Administration, Topical; Adolescent; Alkylating Agents; Burns, Chemical; Caustics; Child; Child, Pre | 2018 |
How to Approach a Patient With Refractory or Recurrent Benign Esophageal Stricture.
Topics: Algorithms; Clinical Decision-Making; Decision Support Techniques; Dilatation; Electrosurgery; Endos | 2019 |
Mitomycin-C: 'a ray of hope' in refractory corrosive esophageal strictures.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Burns, Chemical; Deglutition Disorders; Dilata | 2014 |
Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures.
Topics: Angiogenesis Inhibitors; Animals; Cicatrix; Disease Models, Animal; Dissection; Drug Therapy, Combin | 2014 |
Topical mitomycin-C application in recurrent esophageal strictures after surgical repair of esophageal atresia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Child; Child, Preschool; Constriction, Patholo | 2014 |
A prospective controlled study to assess the use of mitomycin C in improving the results of esophageal dilatation in post corrosive esophageal stricture in children.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Burns, Chemical; Caustics; Child; Child, Presc | 2015 |
Intramuscular injection of mitomycin C combined with endoscopic dilation for benign esophageal strictures.
Topics: Aged; Alkylating Agents; Anti-Inflammatory Agents; Combined Modality Therapy; Deglutition Disorders; | 2015 |
Management of refractory esophageal stenosis in the pediatric age.
Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Drug Resistance; Esophageal Atresi | 2016 |
Treatment of recurrent esophageal stricture with an insulated-tip electrosurgical knife and mitomycin C.
Topics: Administration, Topical; Aged, 80 and over; Combined Modality Therapy; Electrosurgery; Endoscopy, Ga | 2017 |
Intralesional mitomycin C: successful treatment for benign recalcitrant esophageal stricture.
Topics: Adult; Biopsy, Needle; Esophageal Stenosis; Esophagoscopy; Female; Follow-Up Studies; Humans; Immuno | 2009 |
Mitomycin C decreases the rate of stricture formation in caustic esophageal burns in rats.
Topics: Administration, Topical; Alkalies; Animals; Antibiotics, Antineoplastic; Burns, Chemical; Disease Mo | 2009 |
Fluoroscopy-guided topical application of mitomycin-C in a case of refractory esophageal stricture.
Topics: Administration, Topical; Child, Preschool; Chronic Disease; Esophageal Stenosis; Female; Fluoroscopy | 2010 |
Use of a microporous polytetrafluoroethylene catheter balloon to treat refractory esophageal stricture: a novel technique for delivery of mitomycin C.
Topics: Administration, Topical; Alkylating Agents; Catheterization; Equipment Design; Esophageal Atresia; E | 2011 |
The use of mitomycin C in caustic esophagitis in rats.
Topics: Animals; Burns, Chemical; Caustics; Dilatation; Disease Models, Animal; Esophageal Stenosis; Male; M | 2013 |
Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction.
Topics: Adenocarcinoma; Administration, Topical; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; | 2003 |
Mitomycin C prevents strictures in caustic esophageal burns in rats.
Topics: Alkalies; Animals; Antibiotics, Antineoplastic; Body Weight; Burns, Chemical; Disease Models, Animal | 2005 |
Mitomycin C as an alternative to stent for conservative management of esophageal strictures in children.
Topics: Alkylating Agents; Dilatation; Esophageal Stenosis; Humans; Mitomycin; Stents; Treatment Outcome | 2005 |
Mitomycin C: an alternative conservative treatment for refractory esophageal stricture in children?
Topics: Administration, Topical; Antibiotics, Antineoplastic; Child; Child, Preschool; Dilatation; Esophagea | 2006 |
Mitomycin C in the management of pediatric caustic esophageal strictures: a case report.
Topics: Burns, Chemical; Esophageal Stenosis; Humans; Infant; Male; Mitomycin | 2006 |
Role of mitomycin in upper digestive tract stricture.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Degl | 2007 |
Topical application of mitomycin-C in oesophageal strictures.
Topics: Administration, Topical; Anti-Inflammatory Agents; Child, Preschool; Dilatation; Esophageal Stenosis | 2007 |
[Topical mitomycin C treatment of a benign oesophageal stricture following caustic ingestion in a four-year-old boy].
Topics: Administration, Topical; Burns, Chemical; Caustics; Child, Preschool; Deglutition Disorders; Esophag | 2007 |
[Use of mitomycin C in esophageal stenosis].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Esophageal Stenosis; Female | 2007 |
Topical application of mitomycin C in the treatment of esophageal and tracheobronchial stricture: a report of 2 cases.
Topics: Administration, Topical; Anastomosis, Surgical; Bronchial Diseases; Child; Child, Preschool; Constri | 2007 |
Topical mitomycin-C for recalcitrant esophageal strictures: a novel endoscopic/fluoroscopic technique for safe endoluminal delivery.
Topics: Administration, Topical; Adult; Burns, Chemical; Catheterization; Child, Preschool; Deglutition Diso | 2008 |
A child with oesophageal strictures.
Topics: Burns, Chemical; Caustics; Dilatation; Esophageal Stenosis; Female; Humans; Infant; Mitomycin | 2002 |